← Leaderboards
James Jing Cai
Texas A&M University
$758,576
Attributed
$2,084,040
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $585.6K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,084,040 · 2
By mechanism
R01$1,700,667 · 1
R21$383,373 · 1
Top collaborators
- Maen Abdelrahim3 shared
- Stephen H Safe3 shared
- Xiaorong Lin2 shared
Most similar at Texas A&M University
Same institution · by research overlap
- Stephen H Safe$17,757,115
- Maen Abdelrahim$566,889
- Seth William Coleman$145,200
Others in their field
Top investigators on “Overexpression”
- Andrzej Joachimiak Joachimiak · University Of Chicago$32,767,365
- Benjamin L Handen · University Of Pittsburgh At Pittsburgh$24,209,146
- C Kent Osborne · Baylor College Of Medicine$23,157,545
- Norbert Perrimon · Harvard Medical School$23,056,106
- Philipp E Scherer · Ut Southwestern Medical Center$21,324,642
- Susan E Celniker · University Of Calif-Lawrenc Berkeley Lab$20,387,203
Research focus
OverexpressionInfectionLinkMouse ModelGenesGeneticGrowthMolecularPlayCellsAntagonistAffinityCancer CellCancer DiagnosisAngiogenesisColonic NeoplasmsColorectal CancerBindingCessation Of LifeClinical ApplicationChemopreventive AgentChemotherapeutic AgentChemotherapyColon
Grant awards (5)
NR4A1 Antagonists Inhibit Colorectal Cancer Growth and Enhance Immune Surveillance$571,380
R01 · FY2025 · CA
NR4A1 Antagonists Inhibit Colorectal Cancer Growth and Enhance Immune Surveillance$543,717
R01 · FY2024 · CA
NR4A1 Antagonists Inhibit Colorectal Cancer Growth and Enhance Immune Surveillance$585,570
R01 · FY2023 · CA
MADS-box transcriptional regulation of dimorphic transition in Penicillium marneffei$167,061
R21 · FY2017 · AI · contact PI
MADS-box transcriptional regulation of dimorphic transition in Penicillium marneffei$216,312
R21 · FY2016 · AI · contact PI